Scilex Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SCILEX PHARMS, and when can generic versions of SCILEX PHARMS drugs launch?
SCILEX PHARMS has three approved drugs.
There are eighteen US patents protecting SCILEX PHARMS drugs.
There are sixty patent family members on SCILEX PHARMS drugs in twenty-four countries and one supplementary protection certificate in one country.
Summary for Scilex Pharms
| International Patents: | 60 |
| US Patents: | 18 |
| Tradenames: | 3 |
| Ingredients: | 3 |
| NDAs: | 3 |
Drugs and US Patents for Scilex Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scilex Pharms | ELYXYB | celecoxib | SOLUTION;ORAL | 212157-001 | May 5, 2020 | RX | Yes | Yes | 10,799,517 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Scilex Pharms | ELYXYB | celecoxib | SOLUTION;ORAL | 212157-001 | May 5, 2020 | RX | Yes | Yes | 10,722,456 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Scilex Pharms | ZTLIDO | lidocaine | PATCH;TOPICAL | 207962-001 | Feb 28, 2018 | RX | Yes | Yes | 9,931,403 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Scilex Pharms Drugs
Supplementary Protection Certificates for Scilex Pharms Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0731795 | 10075033 | Germany | ⤷ Sign Up | PRODUCT NAME: CELECOXIB; NAT. REGISTRATION NO/DATE: 48802.00.00 20000518; FIRST REGISTRATION: SE 14838 19991203 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
